QAS.AI

QAS.AI is building real-time intraoperative AI for neurovascular care. Our platform integrates into angiography workflow and provides actionable treatment insight while the patient is still on the table. We are initially focused on intracranial aneurysm treatment, helping physicians reduce uncertainty, improve procedural decisions, and decrease retreatments. QAS.AI is a University at Buffalo spinout with clinical integration work across leading imaging environments, strong non-dilutive funding t[1][2]

Visit website Suggest an update

2020 Founded

Overview

QAS.AI is a medical device company [3] that develops real-time intraoperative artificial intelligence for neurovascular care [2]. The company's platform integrates into angiography workflow and provides actionable treatment insight during procedures while patients remain on the operating table [2]. QAS.AI initially focuses on intracranial aneurysm treatment, with the goal of helping physicians reduce uncertainty, improve procedural decisions, and decrease retreatments [2]. The company is a spinout from the University at Buffalo [2] and has conducted clinical integration work across leading imaging environments [2]. QAS.AI was founded in 2020 [2] and has secured non-dilutive funding [2].

Business address: 701 Ellicott St, Buffalo, New York, 14203. [6]

Growth & traction

LinkedIn lists 8 people working at QAS.AI. [4]

Something wrong or missing? Send an update. Fixed within 24 hours.